Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
CURRENT ASSETS:
Cash and cash equivalents	$ 22,037	$ 17,703
Accounts receivable, net of allowance for credit losses of $3,448 and $3,225 at 2022 and 2021, respectively	98,900	96,830
Inventories	48,224	45,443
Prepaid expenses	13,611	14,059
Income taxes receivable	14,640	9,911
Other current assets	4,780	5,109
TOTAL CURRENT ASSETS	202,192	189,055
PROPERTY, PLANT AND EQUIPMENT, net of accumulate depreciation of $306,542 and $306,461 at 2022 and 2021, respectively	109,926	110,952
RIGHT OF USE ASSETS	60,168	61,387
INTANGIBLES, net of accumulated amortization of $[17,369] and $17,540 at 2022 and 2021, respectively	7,979	8,139
GOODWILL	99,445	99,445
DEFERRED TAX ASSETS, net	67,698	70,462
OTHER ASSETS	37,510	41,413
TOTAL ASSETS	584,918	580,853
CURRENT LIABILITIES:
Accounts payable	34,405	29,726
Accrued payroll and related costs	26,465	20,833
Taxes other than payroll and income	4,795	5,931
Unearned revenues	7,602	7,765
Operating lease liabilities	12,669	12,342
Income taxes payable	5,784	6,502
Other current liabilities	8,042	7,683
TOTAL CURRENT LIABILITIES	99,762	90,782
LONG-TERM DEBT, net	189,807	188,636
LONG-TERM OPERATING LEASE LIABILITIES	46,883	49,286
DEFERRED COMPENSATION	34,527	39,101
DEFERRED TAX LIABILITIES, net	23,270	24,336
OTHER LONG-TERM LIABILITIES	24,283	27,711
COMMITMENTS AND CONTINGENCIES
EQUITY:
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 46,454,264 issued and 46,283,676 outstanding at 2022 and 46,454,264 issued and 46,349,397 outstanding at 2021	1,188	1,188
Additional paid-in capital	107,088	101,120
Retained earnings	65,998	68,349
Accumulated other comprehensive income (loss)	(6,753)	(10,133)
Treasury shares (at cost), 170,588 at 2022 and 104,867 at 2021	(5,736)	(4,075)
Total Core Laboratories N.V. shareholders' equity	161,785	156,449
Non-controlling interest	4,601	4,552
TOTAL EQUITY	166,386	161,001
TOTAL LIABILITIES AND EQUITY	$ 584,918	$ 580,853